3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Motor Activity
1
Lymphoma
1
Leukemia
1
Interventions
Magnetic Resonance Spectroscopy
12
pembrolizumab
8
Nivolumab
8
Biopsy
7
Radiotherapy
6
Temozolomide
4
Specimen Handling
4
Radiosurgery
4
Cyclophosphamide
4
fludarabine
3
X-Rays
3
Surgical Procedures, Operative
3
Paclitaxel
3
Leukapheresis
3
Ipilimumab
3
Fluorodeoxyglucose F18
3
Aspirin
3
perflutren
2
alovudine
2
Tirzepatide
2
Rituximab
2
Positron-Emission Tomography
2
Phantoms, Imaging
2
Omeprazole
2
Niacinamide
2
Neoadjuvant Therapy
2
Losartan
2
Letrozole
2
Ketoconazole
2
Immunotherapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Nadolol
×
90 days
×
Clear all
NCT06643221
2026-06-05
Allo-X
University of Arizona
Phase EARLY_PHASE1
Recruiting
200 enrolled